Skip to main content
Tech.euFundingExplorerBeta

Versant Ventures

Investor profile

Investment firm

Versant Ventures has backed 6 European tech companies across 9 funding rounds between 2014 and 2026, joining rounds totalling €505M. Most active in Healthtech. Data as of Nov 2026.

Deals
9
distinct rounds
Companies
6
backed
Active span
2014–2026
13 yrs
Total round €
€505M
sum of rounds joined

Deals by year

distinct rounds / year
Versant Ventures — deals by year — interactive chart.
Data table
Versant Ventures — deals by year
20141
20151
20161
20171
20211
20221
20242
20261

Top sectors

by deals
Versant Ventures — top sectors — interactive chart.
Data table
Versant Ventures — top sectors
Healthtech9

Stages

by deals
Versant Ventures — stages — interactive chart.
Data table
Versant Ventures — stages
Series B5
Series A4

Countries

by deals
Versant Ventures — countries — interactive chart.
Data table
Versant Ventures — countries
Switzerland6
Denmark1
Germany1
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Versant Ventures — 9 dealsVersant VenturesLSP — 3 shared deals · click to openLSP5AM Ventures — 2 shared deals · click to open5AM VenturesAbingworth LLP — 2 shared deals · click to openAbingworth LLPAndera Partners — 2 shared deals · click to openAndera PartnersPanakès Partners — 2 shared deals · click to openPanakès PartnersSR One — 2 shared deals · click to openSR OneAngelini Ventures — 1 shared deals · click to openAngelini VenturesBayer Global Investments — 1 shared deals · click to openBayer Global InvestmentsBpifrance — 1 shared deals · click to openBpifranceCaaS Capital Management — 1 shared deals · click to openCaaS Capital ManagementCasdin Capital — 1 shared deals · click to openCasdin CapitalCDP Venture Capital — 1 shared deals · click to openCDP Venture CapitalCelgene — 1 shared deals · click to openCelgeneDawn Biopharma — 1 shared deals · click to openDawn BiopharmaEpidarex Capital — 1 shared deals · click to openEpidarex CapitalEQT Life Sciences — 1 shared deals · click to openEQT Life SciencesEuropean Investment Bank (EIB) — 1 shared deals · click to openEuropean Investment Bank (EIB)Export and Investment Fund of Denmark (EIFO) — 1 shared deals · click to openExport and Investment Fund of Denmark (EIFO)

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
NouscomSwitzerland3€174M
T-knifeGermany1€93M
CRISPR TherapeuticsSwitzerland2€82M
Antag TherapeuticsDenmark1€80M
Cimeio TherapeuticsSwitzerland1€46M
Enterprise TherapeuticsUK1€30M

Biggest deals

top 10 by amount
CompanyStageAmountDate
T-knifeSeries B€93M2021-08
Antag TherapeuticsSeries A€80M2024-12
CRISPR TherapeuticsSeries B€59M2015-04
Cimeio TherapeuticsSeries A€46M2022-04
NouscomSeries B€42M2017-11
Enterprise TherapeuticsSeries B€30M2024-01
CRISPR TherapeuticsSeries A€23M2014-04
NouscomSeries A€12M2016-05
← Back to investors